Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2554686 | Life Sciences | 2006 | 4 Pages |
Abstract
Activation of A1 or A2A receptors has been shown to induce antinociceptive effects, and the possible involvement of adenosine in (â)-linalool antinociceptive effect, has not been elucidated yet. Therefore, in the present study, we have investigated the effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a selective adenosine A1 receptor antagonist and the effects of 3,7-dimethyl-1-propargilxanthine (DMPX), a selective adenosine A2A receptor antagonist on the antinociception of (â)-linalool in mice, measured in the hot-plate test. Both DPCPX (0.1 mg/kg; i.p.) and DMPX (0.1 mg/kg; i.p.) pre-treatment significantly depressed the antinociceptive effect of (â)-linalool at the highest doses tested. These findings demonstrated that the effect of (â)-linalool on pain responses is, at least partially, mediated by the activity of adenosine A1 and A2A receptors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alessandra T. Peana, Paolo Rubattu, Gian Giorgio Piga, Silvia Fumagalli, Giampiero Boatto, Proto Pippia, M. Graziella De Montis,